Lipocine Inc.
LPCNBiotechnology
$1.44−5.26%As of Oct 30vs prior close
- Market cap
- $11.9M
- P/E (TTM)
- –
- P/E (FY1)
- 0.2×
- From 52W high
- −87.21%
- EPS (LTM)
- -$1.79
- Revenue (LTM)
- $1.6M
- Net margin
- -755.13%
- Dividend yield
- 0.00%
Nomior Score
35
Steady ProfileSpeculativeBottom 21% of the scored universe
Growth—
Quality35
Value—
Momentum40
Resilience34
Growth
$1.6Mrevenue, LTM
YE16 $0LTM $1.6M
Connections
Revenue to profitQ2 YE26
The operating loss was 1495% of revenue, wider by 1109 pts on a year.
Who owns it
1fund